Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial

Articolo
Data di Pubblicazione:
2018
Citazione:
Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial / Gammie, James S.; Bartus, Krzysztof; Gackowski, Andrzej; D'Ambra, Michael N.; Szymanski, Piotr; Bilewska, Agata; Kusmierczyk, Mariusz; Kapelak, Boguslaw; Rzucidlo-Resil, Jolanta; Moat, Neil; Duncan, Alison; Yadev, Rashmi; Livesey, Steve; Diprose, Paul; Gerosa, Gino; D'Onofrio, Augusto; Pitterello, Demetrio; Denti, Paolo; La Canna, Giovanni; De Bonis, Michele; Alfieri, Ottavio; Hung, Judy; Kolsut, Piotr. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 71:1(2018), pp. 25-36. [10.1016/j.jacc.2017.10.062]
Abstract:
Background Conventional mitral valve (MV) operations allow direct anatomic assessment and repair on an arrested heart, but require cardiopulmonary bypass, aortic cross-clamping, sternotomy or thoracotomy, and cardioplegic cardiac arrest, and are associated with significant perioperative disability, and risks of morbidity and mortality. Objectives This study evaluated safety and performance of a transesophageal echocardiographic-guided device designed to implant artificial expanded polytetrafluoroethylene (ePTFE) cords on mitral leaflets in the beating heart. Methods In a prospective multicenter study, 30 consecutive patients with severe degenerative mitral regurgitation (MR) were treated with a mitral valve repair system (MVRS) via small left thoracotomy. The primary (30-day) endpoint was successful implantation of cords with MR reduction to moderate or less. Results The primary endpoint was met in 27 of 30 patients (90%). Three patients required conversion to open mitral surgery. There were no deaths, strokes, or permanent pacemaker implantations. At 1 month, MR was mild or less in 89% (24 of 27) and was moderate in 11% (3 of 27). At 6 months, MR was mild or less in 85 % (22 of 26), moderate in 8% (2 of 26), and severe in 8% (2 of 26). Favorable cardiac remodeling at 6 months included decreases in end-diastolic (161 ± 36 ml to 122 ± 30 ml; p < 0.001) and left atrial volumes (106 ± 36 ml to 69 ± 24 ml; p < 0.001). The anterior-posterior mitral annular dimension decreased from 34.7 ± 5.8 mm to 28.2 ± 5.1 mm; p < 0.001 as did the mitral annular area (10.0 ± 2.7 cm2vs. 6.9 ± 2.0 cm2; p < 0.0001). Conclusions MVRS ePTFE cordal implantation can reduce the invasiveness and morbidity of conventional MV surgery. The device's safety profile is promising and prospective trials comparing the outcomes of the MVRS to conventional MV repair surgery are warranted. (CE Mark Study for the Harpoon Medical Device [TRACER]; NCT02768870)
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
echocardiography; mitral valve; regurgitation; surgery; valvuloplasty; Cardiology and Cardiovascular Medicine
Elenco autori:
Gammie, James S.; Bartus, Krzysztof; Gackowski, Andrzej; D'Ambra, Michael N.; Szymanski, Piotr; Bilewska, Agata; Kusmierczyk, Mariusz; Kapelak, Boguslaw; Rzucidlo-Resil, Jolanta; Moat, Neil; Duncan, Alison; Yadev, Rashmi; Livesey, Steve; Diprose, Paul; Gerosa, Gino; D'Onofrio, Augusto; Pitterello, Demetrio; Denti, Paolo; La Canna, Giovanni; De Bonis, Michele; Alfieri, Ottavio; Hung, Judy; Kolsut, Piotr
Autori di Ateneo:
DE BONIS MICHELE
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/79181
Pubblicato in:
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Journal
  • Dati Generali

Dati Generali

URL

www.elsevier.com/locate/jacc
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0